Čájehuvvojit 1 - 6 oktiibuot 6 bohtosis ohcui Helen Gandler (15054017)', ohcanáigi: 0,01s Aiddostahte ozu
  1. 1
    Figure S1 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates

    Figure S1 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates Dahkki Evan C. Chen (15054014)

    Almmustuhtton 2025
    Eará dahkkit: “…Helen Gandler (15054017)…”
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Figure S3 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates

    Figure S3 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates Dahkki Evan C. Chen (15054014)

    Almmustuhtton 2025
    Eará dahkkit: “…Helen Gandler (15054017)…”
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Figure S4 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates

    Figure S4 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates Dahkki Evan C. Chen (15054014)

    Almmustuhtton 2025
    Eará dahkkit: “…Helen Gandler (15054017)…”
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    Figure S2 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates

    Figure S2 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates Dahkki Evan C. Chen (15054014)

    Almmustuhtton 2025
    Eará dahkkit: “…Helen Gandler (15054017)…”
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    Figure S6 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates

    Figure S6 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates Dahkki Evan C. Chen (15054014)

    Almmustuhtton 2025
    Eará dahkkit: “…Helen Gandler (15054017)…”
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    Figure S5 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates

    Figure S5 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates Dahkki Evan C. Chen (15054014)

    Almmustuhtton 2025
    Eará dahkkit: “…Helen Gandler (15054017)…”
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: